The down regulation of target genes by photo activated DNA nanoscissors

Biomaterials

Volumn 31, Issue 25, 2010, Pages 6545-6554

  Tsai, Tsung Lin ^a   Shieh, Dar Bin ^a   Yeh, Chen Sheng ^a   Tzeng, Yonhua ^a   Htet, Khant ^b   Chuang, Kao Shu ^c   Hwu, Jih Ru ^c   Su, Wu Chou ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

DNA cleavge; Gene manipulation; Gold nanoparticles; Hydrazone; Triplex forming oligonucleotides (TFOs)

Indexed keywords

GENE MANIPULATION; GOLD NANOPARTICLES; HYDRAZONES; TRIPLEX-FORMING OLIGONUCLEOTIDES; TRIPLEX-FORMING OLIGONUCLEOTIDES (TFOS);

DNA; DNA SEQUENCES; ELECTROPHORETIC MOBILITY; GOLD; MONOLAYERS; NANOPARTICLES; OLIGONUCLEOTIDES; PRECIPITATION (CHEMICAL); TARGETS;

GENES;

ARTIFICIAL TARGETED LIGHT ACTIVATED NANOSCISSOR; DOUBLE STRANDED DNA; GOLD NANOPARTICLE; HYDRAZONE DERIVATIVE; NANOMATERIAL; OLIGONUCLEOTIDE; PLASMID DNA; UNCLASSIFIED DRUG; DNA; GOLD; NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA CLEAVAGE; DOWN REGULATION; ELECTROPHORETIC MOBILITY; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; GENE TECHNOLOGY; GENETIC MANIPULATION; HELA CELL; HUMAN; HUMAN CELL; ILLUMINATION; MOLECULAR RECOGNITION; NANOPROBE; PARTICLE SIZE; PHOTOACTIVATION; PRECIPITATION; PRIORITY JOURNAL; CHEMISTRY; GENE; GENETICS; HELA CELL LINE; METABOLISM; PHOTOCHEMISTRY;

DNA; DNA CLEAVAGE; DOWN-REGULATION; GENES; GOLD; HELA CELLS; HUMANS; HYDRAZONES; NANOPARTICLES; PHOTOCHEMICAL PROCESSES;

EID: 77953961678     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.058     Document Type: Article

References (38)

1. Macickova-Cahova H., Hocek M. Cleavage of adenine-modified functionalized DNA by type II restriction endonucleases. Nucleic Acids Res 2009, 37:7612-7622.
2. Weisbrod S.H., Marx A. Novel strategies for the site-specific covalent labelling of nucleic acids. Chem Commun (Camb) 2008, 30:5675-5685.
3. Hocek M., Fojta M. Cross-coupling reactions of nucleoside triphosphates followed by polymerase incorporation. Construction and applications of base-functionalized nucleic acids. Org Biomol Chem 2008, 6:2233-2241.
4. Cross D., Burmester J.K. Gene therapy for cancer treatment: past, present and future. Clin Med Res 2006, 4:218-227.
5. Frank O., Rudolph C., Heberlein C., von Neuhoff N., Schrock E., Schambach A., et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood 2004, 104:3543-3549.
6. Patil S.D., Rhodes D.G., Burgess D.J. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 2005, 7:E61-E77.
7. Kim D.H., Rossi J.J. Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007, 8:173-184.
8. Felsenfeld G., Davies D.R., Rich A. Formation of a three stranded polynucleotide molecule. J Am Chem Soc 1957, 79:2023.
9. Frank-Kamenetskii M.D., Mirkin S.M. Triplex DNA structures. Annu Rev Biochem 1995, 64:65-95.
10. Besch R., Giovannangeli C., Degitz K. Triplex-forming oligonucleotides - sequence-specific DNA ligands as tools for gene inhibition and for modulation of DNA-associated functions. Curr Drug Targets 2004, 5:691-703.
11. Casey B.P., Glazer P.M. Gene targeting via triple-helix formation. Prog Nucleic Acid Res Mol Biol 2001, 67:163-192.
12. Fox K.R. Targeting DNA with triplexes. Curr Med Chem 2000, 7:17-37.
13. Guntaka R.V., Varma B.R., Weber K.T. Triplex-forming oligonucleotides as modulators of gene expression. Int J Biochem Cell Biol 2003, 35:22-31.
14. Vasquez K.M., Wilson J.H. Triplex-directed modification of genes and gene activity. Trends Biochem Sci 1998, 23:4-9.
15. Ye Z., Guntaka R.V., Mahato R.I. Sequence-specific triple helix formation with genomic DNA. Biochemistry 2007, 46:11240-11252.
16. Hwu J.R., Lin C.C., Chuang S.H., King K.Y., Su T.R., Tsay S.C. Aminyl and iminyl radicals from arylhydrazones in the photo-induced DNA cleavage. Bioorg Med Chem 2004, 12:2509-2515.
17. Ceruti J.M., Scassa M.E., Flo J.M., Varone C.L., Canepa E.T. Induction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cells. Oncogene 2005, 24:4065-4080.
18. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993, 8:307-318.
19. Eisenschmidt K., Lanio T., Simoncsits A., Jeltsch A., Pingoud V., Wende W., et al. Developing a programmed restriction endonuclease for highly specific DNA cleavage. Nucleic Acids Res 2005, 33:7039-7047.
20. Datta K., Weinfeld M., Neumann R.D., Winters T.A. Determination and analysis of site-specific 125I decay-induced DNA double-strand break end-group structures. Radiat Res 2007, 167:152-166.
21. Panyutin I.G., Sedelnikova O.A., Karamychev V.N., Neumann R.D. Antigene radiotherapy: targeted radiodamage with 125i-labeled triplex-forming oligonucleotides. Ann N Y Acad Sci 2003, 1002:134-140.
22. Sedelnikova O.A., Panyutin I.G., Luu A.N., Reed M.W., Licht T., Gottesman M.M., et al. Targeting the human mdr1 gene by 125I-labeled triplex-forming oligonucleotides. Antisense Nucleic Acid Drug Dev 2000, 10:443-452.
23. Hsu M.H., Josephrajan T., Yeh C.S., Shieh D.B., Su W.C., Hwu J.R. Novel arylhydrazone-conjugated gold nanoparticles with DNA-cleaving ability: the first DNA-nicking nanomaterial. Bioconjug Chem 2007, 18:1709-1712.
24. Corish P., Tyler-Smith C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 1999, 12:1035-1040.
25. Yu P.H., Davis B.A. Deuterium isotope effects in the ninhydrin reaction of primary amines. Experientia 1982, 38:299-300.
26. Fu E., Ramsey S.A., Yager P. Dependence of the signal amplification potential of colloidal gold nanoparticles on resonance wavelength in surface plasmon resonance-based detection. Anal Chim Acta 2007, 599:118-123.
27. Shumaker-Parry J.S., Zareie M.H., Aebersold R., Campbell C.T. Microspotting streptavidin and double-stranded DNA arrays on gold for high-throughput studies of protein-DNA interactions by surface plasmon resonance microscopy. Anal Chem 2004, 76:918-929.
28. Kobori A., Horie S., Suda H., Saito I., Nakatani K. The SPR sensor detecting cytosine[bond]cytosine mismatches. J Am Chem Soc 2004, 126:557-562.
29. Storhoff J.J., Elghanian R., Mirkin C.A., Letsinger R.L. Sequence-Dependent stability of DNA-Modified gold nanoparticles. Langmuir 2002, 18:6666-6670.
30. Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther 1999, 6:482-497.
31. Datta A., Nicot C. Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells. Oncogene 2008, 27:1135-1141.
32. Pante N., Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39nm. Mol Biol Cell 2002, 13:425-434.
33. Alber F., Dokudovskaya S., Veenhoff L.M., Zhang W., Kipper J., Devos D., et al. Determining the architectures of macromolecular assemblies. Nature 2007, 450:683-694.
34. Hwang H.W., Wentzel E.A., Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315:97-100.
35. Christensen L.A., Finch R.A., Booker A.J., Vasquez K.M. Targeting oncogenes to improve breast cancer chemotherapy. Cancer Res 2006, 66:4089-4094.
36. Jain A., Wang G., Vasquez K.M. DNA triple helices: biological consequences and therapeutic potential. Biochimie 2008, 90:1117-1130.
37. Liu Y., Nairn R.S., Vasquez K.M. Processing of triplex-directed psoralen DNA interstrand crosslinks by recombination mechanisms. Nucleic Acids Res 2008, 36:4680-4688.
38. Cannata F., Brunet E., Perrouault L., Roig V., Ait-Si-Ali S., Asseline U., et al. Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification. Proc Natl Acad Sci U S A 2008, 105:9576-9581.